392 related articles for article (PubMed ID: 19788508)
1. Delayed hemolytic transfusion reaction with hyperhemolysis after first red blood cell transfusion in child with beta-thalassemia: challenges in treatment.
Hannema SE; Brand A; van Meurs A; Smiers FJ
Transfusion; 2010 Feb; 50(2):429-32. PubMed ID: 19788508
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of serologic markers related to red blood cell autoantibodies production after red blood cell transfusion-severe autoimmune hemolytic anemia occurring after transfusion and alloimmunization: successful treatment with rituximab.
Sigler E; Shvidel L; Yahalom V; Berrebi A; Shtalrid M
Transfusion; 2009 Jul; 49(7):1370-4. PubMed ID: 19374728
[TBL] [Abstract][Full Text] [Related]
3. Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch.
Scholl S; Klink A; Mügge LO; Schilling K; Höffken K; Sayer HG
Transfusion; 2005 Oct; 45(10):1676-83. PubMed ID: 16181220
[TBL] [Abstract][Full Text] [Related]
4. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP
Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
[TBL] [Abstract][Full Text] [Related]
5. Severe neurologic complication after delayed hemolytic transfusion reaction in 2 children with sickle cell anemia: significant diagnosis and therapeutic challenges.
Elenga N; Mialou V; Kebaïli K; Galambrun C; Bertrand Y; Pondarre C
J Pediatr Hematol Oncol; 2008 Dec; 30(12):928-30. PubMed ID: 19131783
[TBL] [Abstract][Full Text] [Related]
6. Hyperhemolysis syndrome in anemia of chronic disease.
Darabi K; Dzik S
Transfusion; 2005 Dec; 45(12):1930-3. PubMed ID: 16371046
[TBL] [Abstract][Full Text] [Related]
7. Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease.
Noizat-Pirenne F; Bachir D; Chadebech P; Michel M; Plonquet A; Lecron JC; Galactéros F; Bierling P
Haematologica; 2007 Dec; 92(12):e132-5. PubMed ID: 18055978
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
Aygun B; Padmanabhan S; Paley C; Chandrasekaran V
Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310
[TBL] [Abstract][Full Text] [Related]
9. Hyperhemolysis syndrome in a patient without a hemoglobinopathy, unresponsive to treatment with eculizumab.
Gupta S; Fenves A; Nance ST; Sykes DB; Dzik WS
Transfusion; 2015 Mar; 55(3):623-8. PubMed ID: 25257194
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.
Zakerinia M; Khojasteh HN; Ramzi M; Haghshenas M
Transplant Proc; 2005 Dec; 37(10):4477-81. PubMed ID: 16387149
[TBL] [Abstract][Full Text] [Related]
11. A delayed hemolytic transfusion reaction (DHTR) with multiple alloantibodies (Anti-E, Jka, Dia, Fyb, and S) induced by E-antigen-negative, crossmatch-compatible blood.
Yamane K; Yagihashi A; Sasaki M; Kuwashima K; Morio A; Watanabe N
Immunopharmacol Immunotoxicol; 1998 Nov; 20(4):531-9. PubMed ID: 9805232
[TBL] [Abstract][Full Text] [Related]
12. Peripheral blood stem cell transplantation in children with beta-thalassemia major.
Farzana T; Shamshi TS; Irfan M; Ansari SH; Baig MI; Shakoor N
J Coll Physicians Surg Pak; 2003 Apr; 13(4):204-6. PubMed ID: 12718774
[TBL] [Abstract][Full Text] [Related]
13. Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning.
Canals C; Muñiz-Díaz E; Martínez C; Martino R; Moreno I; Ramos A; Arilla M; Boto N; Pastoret C; Remacha A; Sierra J; Madoz P
Transfusion; 2004 Nov; 44(11):1603-11. PubMed ID: 15504166
[TBL] [Abstract][Full Text] [Related]
14. Anti-N and anti-Do
Unnikrishnan A; Pelletier JPR; Bari S; Zumberg M; Shahmohamadi A; Spiess BD; Michael MJ; Harris N; Harrell D; Mandernach MW
Transfusion; 2019 Jun; 59(6):1907-1910. PubMed ID: 30768787
[TBL] [Abstract][Full Text] [Related]
15. Malaria infection after allogeneic bone marrow transplantation in a child with thalassemia.
Tran VB; Tran VB; Lin KH
Bone Marrow Transplant; 1997 Jun; 19(12):1259-60. PubMed ID: 9208123
[TBL] [Abstract][Full Text] [Related]
16. Second transplant for a thalassemia patient after graft rejection: with immunosuppression and allogeneic peripheral blood stem cell.
Li CK; Shing MM; Chik KW; Lee V; Tsang KS; Yuen PM
Pediatr Hematol Oncol; 2002 Jun; 19(4):267-71. PubMed ID: 12051594
[TBL] [Abstract][Full Text] [Related]
17. Hemolytic transfusion reaction after preoperative prophylactic blood transfusion for sickle cell disease in pregnancy.
Proudfit CL; Atta E; Doyle NM
Obstet Gynecol; 2007 Aug; 110(2 Pt 2):471-4. PubMed ID: 17666632
[TBL] [Abstract][Full Text] [Related]
18. Transfusion management of sickle cell patients during bone marrow transplantation with matched sibling donor.
McPherson ME; Anderson AR; Haight AE; Jessup P; Castillejo MI; Hillyer CD; Josephson CD
Transfusion; 2009 Sep; 49(9):1977-86. PubMed ID: 19453984
[TBL] [Abstract][Full Text] [Related]
19. Impact of pretransplant splenectomy on patients with beta-thalassemia major undergoing a matched-related allogeneic stem cell transplantation.
Mathews V; George B; Lakshmi KM; Viswabandya A; John JM; Sitaram U; Daniel D; Chandy M; Srivastava A
Pediatr Transplant; 2009 Mar; 13(2):171-6. PubMed ID: 18482210
[TBL] [Abstract][Full Text] [Related]
20. Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major.
Ghavamzadeh A; Iravani M; Ashouri A; Mousavi SA; Mahdavi N; Shamshiri A; Hadjibabaie M; Namdar R; Nedaeifard L; Ghaffari H; Alimoghaddam K
Biol Blood Marrow Transplant; 2008 Mar; 14(3):301-8. PubMed ID: 18275896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
